{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:23:28Z","timestamp":1786591408859,"version":"build-2736575974"},"reference-count":129,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.tips.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:15:32Z","timestamp":1628583332000},"page":"829-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives"],"prefix":"10.1016","volume":"42","author":[{"given":"Adriana A.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Koperniku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.B.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Mochly-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.2019000944","article-title":"Glucose-6-phosphate dehydrogenase deficiency","volume":"136","author":"Luzzatto","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tips.2021.07.002_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.arcmed.2020.06.006","article-title":"Glucose-6-phosphate dehydrogenase deficiency: an actionable risk factor for patients with COVID-19?","volume":"51","author":"Jamerson","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.tips.2021.07.002_bb0015","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/ijms17122069","article-title":"Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world","volume":"17","author":"G\u00f3mez-Manzo","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.638885","article-title":"G6PD variants and haemolytic sensitivity to primaquine and other drugs","volume":"12","author":"Bancone","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2021.07.002_bb0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/cells8091055","article-title":"The redox role of G6PD in cell growth, cell death, and cancer","volume":"8","author":"Yang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tips.2021.07.002_bb0030","doi-asserted-by":"crossref","first-page":"45963","DOI":"10.1038\/srep45963","article-title":"Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis","volume":"7","author":"Mbanefo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline therapy for latent malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.tips.2021.07.002_bb0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12916-015-0531-0","article-title":"Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency","volume":"13","author":"Baird","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s12936-018-2564-2","article-title":"G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients","volume":"17","author":"Avalos","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.tips.2021.07.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107788","article-title":"Current investigations on clinical pharmacology and therapeutics of glucose-6-phosphate dehydrogenase deficiency","volume":"222","author":"Ryan","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2021.07.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/10715762.2020.1866757","article-title":"G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)","author":"Yang","year":"2021","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tips.2021.07.002_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.clp.2016.01.010","article-title":"Glucose-6-phosphate dehydrogenase deficiency and the need for a novel treatment to prevent kernicterus","volume":"43","author":"Cunningham","year":"2016","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.tips.2021.07.002_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tips.2021.07.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5529256","article-title":"The controversial role of glucose-6-phosphate dehydrogenase deficiency on cardiovascular disease: a narrative review","volume":"2021","author":"Dore","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tips.2021.07.002_bb0075","doi-asserted-by":"crossref","first-page":"14285","DOI":"10.1002\/jcb.29004","article-title":"Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway","volume":"120","author":"Tang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tips.2021.07.002_bb0080","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1038\/s41598-019-40354-7","article-title":"The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0085","first-page":"670","article-title":"Hepatitis A virus-induced severe hemolysis complicated by severe glucose-6-phosphate dehydrogenase deficiency","volume":"22","author":"Sharma","year":"2018","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0090","first-page":"1397","article-title":"Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD deficient patient: a case report","volume":"68","author":"Ahmad","year":"2018","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.tips.2021.07.002_bb0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/tropicalmed4010006","article-title":"Acute retroviral syndrome presenting with hemolytic anemia induced by G6PD deficiency","volume":"4","author":"Araujo","year":"2018","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.tips.2021.07.002_bb0100","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3201\/eid2609.202353","article-title":"Methemoglobinemia in patient with G6PD deficiency and SARS-CoV-2 infection","volume":"26","author":"Palmer","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.tips.2021.07.002_bb0105","article-title":"Methemoglobinemia and hemolytic anemia after COVID-19 infection without identifiable eliciting drug: a case-report","volume":"23","author":"Lopes","year":"2020","journal-title":"IDCases"},{"key":"10.1016\/j.tips.2021.07.002_bb0110","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1002\/ajh.25868","article-title":"The emergence of methemoglobinemia amidst the COVID-19 pandemic","volume":"95","author":"Naymagon","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tips.2021.07.002_bb0115","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1002\/ajh.25862","article-title":"G6PD deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine","volume":"95","author":"Kuipers","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tips.2021.07.002_bb0120","article-title":"Hydroxychloroquine in a G6PD-deficient patient with COVID-19 complicated by haemolytic anaemia: culprit or innocent bystander?","volume":"7","author":"Mastroianni","year":"2020","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tips.2021.07.002_bb0130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/qjmed\/hcaa267","article-title":"COVID-19 & hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia","volume":"113","author":"Chaney","year":"2020","journal-title":"QJM Int. J. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0135","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/20.158","article-title":"Hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient patient receiving hydroxychloroquine for COVID-19: a case report","volume":"24","author":"Aguilar","year":"2020","journal-title":"Perm. J."},{"key":"10.1016\/j.tips.2021.07.002_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/NPM-171696","article-title":"Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: a hospital-based retrospective study","volume":"10","author":"Al-Omran","year":"2017","journal-title":"J. Neonatal. Perinat. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vascn.2016.10.002","article-title":"A new rat model of neonatal bilirubin encephalopathy (kernicterus)","volume":"84","author":"Amini","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tips.2021.07.002_bb0150","first-page":"195","article-title":"Risk factors for sensorineural hearing loss in neonatal hyperbilirubinemia","volume":"30","author":"Boskabadi","year":"2018","journal-title":"Iran J. Otorhinolaryngol."},{"key":"10.1016\/j.tips.2021.07.002_bb0155","article-title":"G6PD overexpression protects from oxidative stress and age-related hearing loss","volume":"00","author":"Berm\u00fadez-Mu\u00f1oz","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.tips.2021.07.002_bb0160","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1523\/JNEUROSCI.0519-17.2017","article-title":"G6PD deficiency does not affect the cytosolic glutathione or thioredoxin antioxidant defense in mouse cochlea","volume":"37","author":"White","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2021.07.002_bb0165","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1096\/fj.201801921R","article-title":"High glucose-induced ubiquitination of G6PD leads to the injury of podocytes","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2021.07.002_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/antiox10020197","article-title":"The pancreatic \u03b2-cell: the perfect redox system","volume":"10","author":"Je\u017eek","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.tips.2021.07.002_bb0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11892-016-0735-5","article-title":"Podocytes: the weakest link in diabetic kidney disease?","volume":"16","author":"Lin","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0180","doi-asserted-by":"crossref","first-page":"H999","DOI":"10.1152\/ajpheart.00488.2020","article-title":"G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases","volume":"320","author":"Dhagia","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tips.2021.07.002_bb0185","doi-asserted-by":"crossref","first-page":"L508","DOI":"10.1152\/ajplung.00165.2020","article-title":"Glucose-6 phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension","volume":"320","author":"Valuparampil Varghese","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.tips.2021.07.002_bb0190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.120.000166","article-title":"Inhibition of G6PD activity attenuates right ventricle pressure and hypertrophy elicited by VEGFR inhibitor + hypoxia","volume":"377","author":"Kitagawa","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2021.07.002_bb0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/cn400079y","article-title":"Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice","volume":"4","author":"Jeng","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tips.2021.07.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118765","article-title":"Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD drosophila model","volume":"10","author":"Besson","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2021.07.002_bb0205","article-title":"DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice","volume":"28","author":"Loniewska","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0210","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2019.10.032","article-title":"A compendium of genetic modifiers of mitochondrial dysfunction reveals intra-organelle buffering","volume":"179","author":"To","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10072-019-03863-x","article-title":"On the central role of mitochondria dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"40","author":"Tobore","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101980","article-title":"Peroxiredoxin 2 oxidation reveals hydrogen peroxide generation within erythrocytes during high-dose vitamin C administration","volume":"43","author":"Pearson","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033458","article-title":"Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis","volume":"9","author":"Fujii","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.tips.2021.07.002_bb0230","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.2146\/ajhp150591","article-title":"I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency","volume":"73","author":"Reeves","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.tips.2021.07.002_bb0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.23182","article-title":"Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase","volume":"88","author":"Sonbol","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tips.2021.07.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223369","article-title":"Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man","volume":"2018","author":"Rehman","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/odi.12446","article-title":"Vitamin C: the known and the unknown and Goldilocks","volume":"22","author":"Padayatty","year":"2016","journal-title":"Oral Dis."},{"key":"10.1016\/j.tips.2021.07.002_bb0250","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0891-5849(96)00123-2","article-title":"Accessibility and reactivity of ascorbate 6-palmitate bound to erythrocyte membranes","volume":"21","author":"May","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0891-5849(98)00198-1","article-title":"Ascorbate 6-palmitate protects human erythrocytes from oxidative damage","volume":"26","author":"Ross","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200084","article-title":"Role of antioxidants and a nutrient rich diet in Alzheimer\u2019s disease","volume":"10","author":"Veurink","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0265","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fncel.2019.00300","article-title":"Local drug delivery for prevention of hearing loss","volume":"13","author":"Rybak","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2021.07.002_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-90-1-53","article-title":"Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies","volume":"90","author":"Spielberg","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0275","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM198008213030802","article-title":"Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency","volume":"303","author":"Corash","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0280","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0022-3476(86)80833-2","article-title":"Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis","volume":"108","author":"Hafez","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tips.2021.07.002_bb0285","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198304283081708","article-title":"High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency","volume":"308","author":"Johnson","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-9120(79)80078-8","article-title":"An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase","volume":"12","author":"Newman","year":"1979","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tips.2021.07.002_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21954","article-title":"Effect of astaxanthin and aluminum chloride on erythrocyte G6PD and 6PGD enzyme activities in vivo and on erythrocyte G6PD in vitro in rats","volume":"31","author":"Temel","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tips.2021.07.002_bb0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lfs.2014.01.059","article-title":"Carotenoids inhibit lipid peroxidation and hemoglobin oxidation, but not the depletion of glutathione induced by ROS in human erythrocytes","volume":"99","author":"Chist\u00e9","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0305","doi-asserted-by":"crossref","DOI":"10.1515\/jcim-2017-0164","article-title":"Evaluating of \u03b2-carotene role in ameliorating of favism-induced disturbances in blood and testis","volume":"15","author":"Koriem","year":"2018","journal-title":"J. Complement. Integr. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.fct.2013.01.055","article-title":"\u03b1-Lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency","volume":"61","author":"Georgakouli","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tips.2021.07.002_bb0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/antiox7110162","article-title":"Exercise and redox status responses following alpha-lipoic acid supplementation in G6PD deficient individuals","volume":"7","author":"Georgakouli","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.tips.2021.07.002_bb0320","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1172\/JCI133530","article-title":"Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion","volume":"130","author":"Francis","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2021.07.002_bb0325","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/ars.2014.6142","article-title":"Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance","volume":"22","author":"Tang","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tips.2021.07.002_bb0330","doi-asserted-by":"crossref","first-page":"23557","DOI":"10.1074\/jbc.M109.067017","article-title":"Glutathione synthesis and turnover in the human erythrocyte: alignment of a model based on detailed enzyme kinetics with experimental data","volume":"285","author":"Raftos","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.07.002_bb0335","first-page":"575","article-title":"Effects of the usage of L-cysteine (L-Cys) on human health","volume":"23","author":"Clemente Plaza","year":"2018","journal-title":"Mol. J. Synth. Chem. Nat. Prod. Chem."},{"key":"10.1016\/j.tips.2021.07.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2835787","article-title":"Biological activities and potential oral applications of N-acetylcysteine: progress and prospects","volume":"2018","author":"Pei","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tips.2021.07.002_bb0345","doi-asserted-by":"crossref","first-page":"19598","DOI":"10.1021\/acsomega.0c02080","article-title":"Protonation equilibria of N-acetylcysteine","volume":"5","author":"Fazary","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.tips.2021.07.002_bb0350","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.biocel.2007.04.014","article-title":"Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes","volume":"39","author":"Raftos","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0355","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00726-018-2559-x","article-title":"l-Cysteine in vitro can restore cellular glutathione and inhibits the expression of cell adhesion molecules in G6PD-deficient monocytes","volume":"50","author":"Parsanathan","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.tips.2021.07.002_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.abb.2018.12.023","article-title":"Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion: Protective role of l-cysteine","volume":"663","author":"Parsanathan","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tips.2021.07.002_bb0365","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","article-title":"NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism","volume":"1","author":"Chen","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tips.2021.07.002_bb0370","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nchembio.2047","article-title":"Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage","volume":"12","author":"Liu","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0375","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ncb1881","article-title":"The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C\u2013Cdh1","volume":"11","author":"Herrero-Mendez","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tips.2021.07.002_bb0380","first-page":"182","article-title":"Red blood cell proteomics update: is there more to discover?","volume":"15","author":"D\u2019Alessandro","year":"2017","journal-title":"Blood Transfus."},{"key":"10.1016\/j.tips.2021.07.002_bb0385","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exphem.2021.01.001","article-title":"Erythroid enucleation: a gateway into a \u201cbloody\u201d world","volume":"95","author":"Menon","year":"2021","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tips.2021.07.002_bb0390","doi-asserted-by":"crossref","first-page":"28329","DOI":"10.18632\/oncotarget.8631","article-title":"Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism","volume":"7","author":"Debeb","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tips.2021.07.002_bb0395","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948375","article-title":"Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis","volume":"20","author":"El-Naggar","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0400","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.V120.21.977.977","article-title":"Gene-selective histone hyperacetylation and enhanced Sp1 occupancy underpin transcriptional modulation of genes of the glycolytic-pentose phosphate pathway in response to histone deacetylase inhibitors \u2013 therapeutic implications","volume":"120","author":"Makarona","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tips.2021.07.002_bb0405","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood-2014-02-553792","article-title":"Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells","volume":"124","author":"Makarona","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tips.2021.07.002_bb0410","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2014-05-575423","article-title":"Epigenetic therapy reprograms hereditary disease","volume":"124","author":"Bautista","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tips.2021.07.002_bb0415","doi-asserted-by":"crossref","first-page":"40252","DOI":"10.1074\/jbc.M110.181073","article-title":"Down-regulation of Myc is essential for terminal erythroid maturation","volume":"285","author":"Jayapal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2021.07.002_bb0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10577-008-9005-y","article-title":"Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation","volume":"17","author":"Popova","year":"2009","journal-title":"Chromosom. Res."},{"key":"10.1016\/j.tips.2021.07.002_bb0425","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1182\/blood-2011-10-387050","article-title":"Protein kinase D-HDAC5 signaling regulates erythropoiesis and contributes to erythropoietin cross-talk with GATA1","volume":"120","author":"Delehanty","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tips.2021.07.002_bb0430","series-title":"Advances in Cancer Research","first-page":"183","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","author":"McClure","year":"2018"},{"key":"10.1016\/j.tips.2021.07.002_bb0435","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3324\/haematol.2010.029827","article-title":"Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts","volume":"95","author":"Ji","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.tips.2021.07.002_bb0440","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2018.10.072","article-title":"Therapeutic potential of selective histone deacetylase 3 inhibition","volume":"162","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2021.07.002_bb0445","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2021.07.002_bb0450","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: emerging indications and novel molecules","author":"Bondarev","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2021.07.002_bb0455","first-page":"72","article-title":"Medications for migraine prophylaxis","volume":"73","author":"Modi","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.tips.2021.07.002_bb0460","first-page":"5734","article-title":"The efficacy and safety of valproate medications for migraine in adults: a meta-analysis","volume":"24","author":"Cui","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0465","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"10.1016\/j.tips.2021.07.002_bb0470","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.biotechadv.2017.12.015","article-title":"Activation of Nrf2 signaling by natural products-can it alleviate diabetes?","volume":"36","author":"Matzinger","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.tips.2021.07.002_bb0475","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4103\/1673-5374.194706","article-title":"The status of Nrf2-based therapeutics: current perspectives and future prospects","volume":"11","author":"Gazaryan","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tips.2021.07.002_bb0480","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000486398","article-title":"Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study","volume":"47","author":"Chin","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.tips.2021.07.002_bb0485","series-title":"Company statement: termination of the BEACON trial","author":"Reata Pharmaceuticals, Inc","year":"2012"},{"key":"10.1016\/j.tips.2021.07.002_bb0490","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cotox.2016.10.005","article-title":"NRF2-targeted therapeutics: new targets and modes of NRF2 regulation","volume":"1","author":"Rojo de la Vega","year":"2016","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.tips.2021.07.002_bb0495","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.celrep.2017.02.048","article-title":"Coupling between protein stability and catalytic activity determines pathogenicity of G6PD variants","volume":"18","author":"Cunningham","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2021.07.002_bb0500","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijbiomac.2017.06.002","article-title":"A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency","volume":"104","author":"Boonyuen","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2021.07.002_bb0505","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-018-06447-z","article-title":"Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator","volume":"9","author":"Hwang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.07.002_bb0510","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/ijms21041523","article-title":"Discovery of small-molecule activators for glucose-6-phosphate dehydrogenase (G6PD) using machine learning approaches","volume":"21","author":"Saddala","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0515","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cmdc.201900341","article-title":"Small-molecule activators of glucose-6-phosephate dehydrogenase (G6PD) bridging the dimer interface","volume":"14","author":"Raub","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tips.2021.07.002_bb0520","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022790118","article-title":"Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency","volume":"118","author":"Horikoshi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2021.07.002_bb0525","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1873-3468.12638","article-title":"Mutations in the tetramer interface of human glucose-6-phosphate dehydrogenase reveals kinetic differences between oligomeric states","volume":"591","author":"Ranzani","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2021.07.002_bb0530","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919838659","article-title":"Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats","volume":"15","author":"Sun","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tips.2021.07.002_bb0535","series-title":"Advances in Clinical Chemistry","first-page":"141","article-title":"Glutathione as a marker for human disease","author":"Teskey","year":"2018"},{"key":"10.1016\/j.tips.2021.07.002_bb0540","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0545","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.freeradbiomed.2017.08.011","article-title":"G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway","volume":"112","author":"Cao","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0550","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0555","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/d41587-019-00026-3","article-title":"First gene therapy for \u03b2-thalassemia approved","volume":"37","author":"Harrison","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2021.07.002_bb0560","author":"European Medicines Agency"},{"key":"10.1016\/j.tips.2021.07.002_bb0565","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0570","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/rme-2016-0010","article-title":"Gene therapies: the challenge of super-high-cost treatments and how to pay for them","volume":"11","author":"Carr","year":"2016","journal-title":"Regen. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0575","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1002\/ajh.24760","article-title":"A somatic mosaicism in the G6PD gene inducing a late onset chronic non-spherocytic hemolytic anemia","volume":"92","author":"Couronn\u00e9","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tips.2021.07.002_bb0580","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jclinane.2018.10.029","article-title":"Laparoscopic cholecystectomy and postoperative pain control in a patient with chronic non-spherocytic hemolytic anemia from glucose-6-phosphate dehydrogenase deficiency","volume":"54","author":"Watanabe","year":"2019","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.tips.2021.07.002_bb0585","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajmg.c.31529","article-title":"Emerging cellular and gene therapies for congenital anemias","volume":"172","author":"Ludwig","year":"2016","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.tips.2021.07.002_bb0590","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-82-6-810_1","article-title":"Ascorbic acid-induced hemolysis in G-6-PD deficiency","volume":"82","author":"Campbell","year":"1975","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0595","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.306.6881.841","article-title":"Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency","volume":"306","author":"Rees","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2021.07.002_bb0600","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5694\/mja17.00998","article-title":"Massive oxidative haemolysis and renal failure caused by high dose vitamin C","volume":"209","author":"Rees","year":"2018","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.tips.2021.07.002_bb0605","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3476(75)80148-X","article-title":"Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid","volume":"86","author":"Mentzer","year":"1975","journal-title":"J. Pediatr."},{"key":"10.1016\/j.tips.2021.07.002_bb0610","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0140-6736(90)92317-B","article-title":"Ascorbic-acid-induced haemolysis in G-6-P-D deficiency","volume":"336","author":"Mehta","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.07.002_bb0615","doi-asserted-by":"crossref","first-page":"2488.e3","DOI":"10.1016\/j.ajem.2020.05.099","article-title":"High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency","volume":"38","author":"Lo","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0620","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5202606","article-title":"Effect of high-dose vitamin C infusion in a glucose-6-phosphate dehydrogenase-deficient patient","volume":"2017","author":"Quinn","year":"2017","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.tips.2021.07.002_bb0625","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3109\/15563650.2014.954124","article-title":"C for colored urine: acute hemolysis induced by high-dose ascorbic acid","volume":"52","author":"Huang","year":"2014","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.tips.2021.07.002_bb0630","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3329\/bjpp.v22i1.3563","article-title":"Effects of vitamin E supplementation on some aspects of hematological variables in patients of hemolytic anemia with glucose 6 phosphate dehydrogenase (G6PD) deficiency","volume":"22","author":"Sultana","year":"1970","journal-title":"Bangladesh J. Physiol. Pharmacol."},{"key":"10.1016\/j.tips.2021.07.002_bb0635","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1749-6632.1982.tb31274.x","article-title":"Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role of vitamin E in its treatment","volume":"393","author":"Corash","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2021.07.002_bb0640","first-page":"731","article-title":"Hemolysis after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency","volume":"34","author":"Wright","year":"1996","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.tips.2021.07.002_bb0645","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.biopsych.2016.02.028","article-title":"N-Acetylcysteine supplementation in an individual with glucose-6-phosphate dehydrogenase deficiency \u2013 associated psychosis","volume":"80","author":"Monsivais","year":"2016","journal-title":"Biol. Psychiatry"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:12:10Z","timestamp":1759050730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":129,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0165614721001371"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.07.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}